Table 4.
Univariate analysis | Multivariate analysis | |||
HR (95% CI) | P value | HR (95% CI) | P value | |
Age >65 years | 5.76 (3.46 to 9.60) | <0.0001 | 3.41 (2.00 to 5.78) | <0.0001 |
Males | 1.58 (1.00 to 2.50) | 0.049 | 1.17 (0.73 to 1.86) | 0.52 |
Exposure to ACE inhibitors | 1.68 (1.03 to 2.74) | 0.04 | 1.28 (0.77 to 2.13) | 0.34 |
Exposure to sartan | 0.91 (0.52 to 1.61) | 0.76 | ||
Exposure to ACE inhibitors or sartan | 1.33 (0.88 to 2.02) | 0.17 | ||
Cardiovascular disease | 2.49 (1.63 to 3.79) | <0.0001 | 1.37 (0.88 to 2.13) | 0.16 |
PaO2/FiO2 ≤200 mm Hg | 6.68 (4.25 to 10.52) | <0.0001 | 3.57 (2.20 to 5.77) | <0.0001 |
Presence of hARF at admission | 15.08 (4.78 to 47.59) | <0.001 | 3.58 (1.05 to 12.18) | 0.04 |
CPAP at admission | 2.20 (1.32 to 3.67) | 0.002 | 1.62 (0.96 to 2.72) | 0.07 |
Multivariate Cox regression analysis that identifies risk factors for in-hospital mortality. Data are reported as HR and 95% CIs.
ACEi, ACE inhibitor; CPAP, continuous positive airway pressure; FiO2, fraction of inhaled oxygen; PaO2, arterial partial pressure of oxygen.